InsiderClue
Stocks · Health care · Medicinal Chemicals & Botanical Products

IM Cannabis Corp.

IMCC Clue Score38
Israel Fiscal year ends December CIK 0001792030
$1.36 -6.85% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.36 −58.66% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 20 May 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue9.1Operating income−10.3Net income−7.3Fiscal year 2020Revenue15.9 +75.1%Operating income−8.2Net income−28.7EPS, diluted−1.90Fiscal year 2021Revenue34.1 +114.3%Operating income−23.0Net income−17.8EPS, diluted−6.70Fiscal year 2022Revenue54.3 +59.6%Operating income−30.8Net income−188.9EPS, diluted−161.88Fiscal year 2023Revenue48.8 −10.2%Operating income−12.8Net income−9.5EPS, diluted−4.45Fiscal year 2024Revenue54.0 +10.7%Operating income−10.2Net income−10.6EPS, diluted−4.51Fiscal year 2025Revenue54.7 +1.3%Operating income−11.6Net income−11.3
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 9.1 15.9 34.1 54.3 48.8 54.0 54.7
Growth +75.1% +114.3% +59.6% −10.2% +10.7% +1.3%
Operating income −10.3 −8.2 −23.0 −30.8 −12.8 −10.2 −11.6
Net income −7.3 −28.7 −17.8 −188.9 −9.5 −10.6 −11.3
Growth
EPS, diluted n/a −1.90 −6.70 −161.88 −4.45 −4.51 n/a

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Gross margin43.3%Operating margin−113.2%Net margin−80.4%Free cash flow margin−82.7%Fiscal year 2020Gross margin65.9%Operating margin−51.9%Net margin−180.6%Free cash flow margin−66.3%Fiscal year 2021Gross margin18.6%Operating margin−67.6%Net margin−52.2%Free cash flow margin−114.4%Fiscal year 2022Gross margin16.9%Operating margin−56.7%Net margin−347.6%Free cash flow margin−26.1%Fiscal year 2023Gross margin20.2%Operating margin−26.2%Net margin−19.5%Free cash flow margin−17.7%Fiscal year 2024Gross margin15.6%Operating margin−18.9%Net margin−19.6%Free cash flow margin−2.3%Fiscal year 2025Gross margin17.7%Operating margin−21.2%Net margin−20.7%Free cash flow margin8.6%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 43.3% 65.9% 18.6% 16.9% 20.2% 15.6% 17.7%
Operating margin −113.2% −51.9% −67.6% −56.7% −26.2% −18.9% −21.2%
Net margin −80.4% −180.6% −52.2% −347.6% −19.5% −19.6% −20.7%
Free cash flow margin −82.7% −66.3% −114.4% −26.1% −17.7% −2.3% 8.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−6.0Capital expenditure−1.5Free cash flow−7.5Fiscal year 2020Operating cash flow−7.9Capital expenditure−2.6Free cash flow−10.5Fiscal year 2021Operating cash flow−34.4Capital expenditure−4.6Free cash flow−39.0Fiscal year 2022Operating cash flow−12.6Capital expenditure−1.6Free cash flow−14.2Fiscal year 2023Operating cash flow−8.1Capital expenditure−0.6Free cash flow−8.7Fiscal year 2024Operating cash flow−1.1Capital expenditure−0.2Free cash flow−1.2Fiscal year 2025Operating cash flow4.7Capital expenditure−0.0Free cash flow4.7
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −6.0 −7.9 −34.4 −12.6 −8.1 −1.1 4.7
Capital expenditure −1.5 −2.6 −4.6 −1.6 −0.6 −0.2 −0.0
Free cash flow −7.5 −10.5 −39.0 −14.2 −8.7 −1.2 4.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securitiesTotal debt
Fiscal year 2019Cash and securities13.9Shareholders’ equity24.7Fiscal year 2020Cash and securities8.9Total debt0.0Net cash (debt)8.9Shareholders’ equity11.1Debt to equity0.00Fiscal year 2021Cash and securities13.9Total debt12.6Net cash (debt)1.3Shareholders’ equity201.2Debt to equity0.06Fiscal year 2022Cash and securities2.4Total debt9.6Net cash (debt)−7.2Shareholders’ equity22.7Debt to equity0.43Fiscal year 2023Cash and securities1.8Total debt12.9Net cash (debt)−11.1Shareholders’ equity14.5Debt to equity0.89Fiscal year 2024Cash and securities0.9Total debt16.1Net cash (debt)−15.2Shareholders’ equity5.2Debt to equity3.07Fiscal year 2025Cash and securities2.7Total debt16.2Net cash (debt)−13.5Shareholders’ equity−3.7
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and securities 13.9 8.9 13.9 2.4 1.8 0.9 2.7
Total debt n/a 0.0 12.6 9.6 12.9 16.1 16.2
Net cash (debt) n/a 8.9 1.3 −7.2 −11.1 −15.2 −13.5
Shareholders’ equity 24.7 11.1 201.2 22.7 14.5 5.2 −3.7
Debt to equity n/a 0.00 0.06 0.43 0.89 3.07 n/a

In millions of CAD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of CAD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−6.0 −7.9 −34.4 −12.6 −8.1 −1.1 4.7
Growth
0.6 0.9 2.1 2.8 n/a n/a n/a
Investment
−1.5 −2.6 −4.6 −1.6 −0.6 −0.2 −0.0
calc −7.5 −10.5 −39.0 −14.2 −8.7 −1.2 4.7
Growth
calc −0.23 −0.27 −6.52 −1.90 −0.68 n/a n/a
−3.8 −4.1 −9.0 −1.5 −1.2 −0.5 −0.5
Financing
17.1 6.7 48.7 4.8 9.4 3.8 1.1

† The diluted share count jumps at 2021 and 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative. Shown in CAD as filed; the screener converts to dollars.